Goldstein et al. have assessed the incidence of upper gastrointestinal complications in patients treated with the COX-2-selective inhibitor, valdecoxib. The authors carried out a predefined ...
Blood-pressure and cardiovascular-safety data on valdecoxib are, however, limited. While some of the cardiovascular effects of COX2-selective inhibitors might be caused by a prostacyclin and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback